| |
original article |
Date |
Title |
Authors All Authors |
| 1 |
[GO] |
2024―Sep―09 |
The Effect of Hemoadsorption with CytoSorb on Severe COVID-19 Complications |
A. S. Rybalko, S. N. Galkina, A. S. Saryglar, A. V. Voronin, M. I. Rezyapova, N. I. Chaus, et al. (+2) S. N. Perekhodov, N. A. Karpun |
| 2 |
[GO] |
2024―Sep―09 |
Veno-Venous Extracorporeal Membrane Oxygenation in COVID-19-Associated ARDS: Predictors of Mortality |
K. A. Mikaelyan, M. A. Petrova, E. V. Filimonova, S. A. Bazanovic |
| 3 |
[GO] |
2024―Feb―21 |
Immune Cell Response of the Spleen in COVID-19 |
S. A. Perepelitsa |
| 4 |
[GO] |
2023―Dec―27 |
Evolution of Techniques and New Protocols for Lung Ultrasound Examination in COVID-19 Pneumonia Patients |
I. S. Shcheparev, B. A. Teplykh, G. S. Kireeva, D. N. Protsenko, D. V. Kotsyubinsky, O. Yu. Bronov, E. A. Balanyuk |
| 5 |
[GO] |
2023―Jun―26 |
Risk Factors for COVID-19 Adverse Outcomes in ICU Settings of Various Types Repurposed Hospitals |
A. A. Avramov, E. V. Ivanov, A. V. Melekhov, R. S. Menzulin, A. I. Nikiforchin |
| 6 |
[GO] |
2023―Jun―26 |
Prognostic Value of Cystatin C as a Predictor of Adverse Outcome in Severe Pneumonia Associated with COVID-19 |
D. I. Korabelnikov, M. O. Magomedaliev, S. E. Khoroshilov |
| 7 |
[GO] |
2023―Apr―27 |
Secondary Infections in Patients with Extremely Severe COVID-19 During ECMO Therapy |
S. S. Andreev, M. V. Ketskalo, P. O. Narusova, M. A. Lysenko |
| 8 |
[GO] |
2023―Apr―27 |
The Predictive Value of Cystatin C for AKI in Patients with COVID-19 |
M. O. Magomedaliev, D. I. Korabelnikov, S. E. Khoroshilov |
| 9 |
[GO] |
2023―Feb―25 |
Predictors of Clinical Efficacy of Cytokine Hemoadsorption in COVID-19 (Clinical Trial) |
V. A. Ratnikov, A. N. Sheglov, S. V. Abramovskiy, I. S. Simutis, M. S. Danilov, G. G. Ivanova, A. A. Syrovatskii |
| 10 |
[GO] |
2022―Dec―22 |
Treating Complications of Extracorporeal Life Support in a Patient with COVID-19 (Case Report) |
A. S. Rybalko, S. N. Galkina, A. S. Saryglar, V. A. Kolerov, A. V. Voronin, S. N. Perekhodov, N. A. Karpun |
| 11 |
[GO] |
2022―Oct―26 |
Regional Cerebral Oxygenation in Patients with Severe COVID-19 |
M. V. Bychinin, S. A. Andreichenko, T. V. Klypa, I. A. Mandel |
| 12 |
[GO] |
2022―Oct―26 |
Hemoadsorption in Patients with Various Types of Respiratory Support for Severe COVID-19 |
R. E. Yakubtsevich, D. N. Rakashevich |
| 13 |
[GO] |
2022―Oct―26 |
Respiratory Mechanics and Gas Exchange in Acute Respiratory Distress Syndrome Associated with COVID-19 |
R. A. Ibadov, D. M. Sabirov, S. Kh. Ibragimov, B. B. Burkhonov, R. R. Ibadov |
| 14 |
[GO] |
2022―Oct―26 |
Acute Myocardial Infarction Complicating Coronavirus Infection (Case Report) |
L. A. Davydova, D. A. Ostapchenko, S. V. Tsarenko, A. I. Gutnikov, G. N. Arbolishvili, V. A. Kovzel |
| 15 |
[GO] |
2022―Aug―26 |
Synthetic Analogue of Leu-Enkephalin in COVID-19 (a Prospective Clinical Study) |
M. A. Magomedov, N. G. Burda , Z. F. Misikov, A. Yu. Ryzhkov, V. V. Antonova, R. A. Cherpakov |
| 16 |
[GO] |
2022―Aug―26 |
Pneumomediastinum: a New Look at an Old Problem in a COVID-19 Pandemic |
O. Y. Chizhova, I. A. Ruslyakova, I. G. Bakulin, N. A. Prokofieva, A. G. Sushilova, G. M. Glazunova, K. M. Lebedinsky |
| 17 |
[GO] |
2022―Feb―27 |
Diaphragm Function Parameters in Patients with Severe COVID-19 |
A. Y. Yakovlev, A. A. Pevnev, M. S. Belous, V. N. Maksimychev, S. I. Chistyakov |
| 18 |
[GO] |
2022―Feb―27 |
Assessment of Clinical Efficacy of Dexamethasone in Patients with Moderate COVID-19 |
M. V. Tolochko, I. N. Leyderman, O. A. Khokhunov, V. A. Mazurok, R. E. Rzheutskya |
| 19 |
[GO] |
2022―Feb―27 |
Nosocomial Infection in Patients with Severe and Critical COVID-19 |
M. V. Bychinin, I. O. Antonov, T. V. Klypa, I. A. Mandel, A. I. Minets, N. A. Kolyshkina, Ya. B. Golobokova |
| 20 |
[GO] |
2022―Feb―27 |
Spontaneous Intramuscular Hematomas in Patients with Severe COVID-19 (Case Report) |
N. A. Lesteva, G. Yu. Rybakov, I. N. Danilov, A. A. Kovalev, A. N. Kondratyev |
| 21 |
[GO] |
2022―Feb―27 |
Risk Factors of Severe Disease and Methods for Clinical Outcome Prediction in Patients with COVID-19 (Review) |
S. V. Sokologorskiy, A. M. Ovechkin, I. V. Khapov, M. E. Politov, E. L. Bulanova |
| 22 |
[GO] |
2022―Feb―27 |
Dexamethasone and SARS-CoV-2: the Dangerous Steroids Pandemic (Letter to the Editorial Office) |
A. Belletti, S. Fresilli, G. Landoni, A. Zangrillo |
| 23 |
[GO] |
2021―Jul―03 |
On the Possibility of Using Succinate in Hypoxia Developing in COVID-19 |
Yu. P. Orlov, N. V. Govorova, O. V. Korpacheva, V. V. Afanasyev, I. A. Khilenko |
| 24 |
[GO] |
2021―Jul―03 |
Efficacy and Safety of Oral Anticoagulants in the Treatment of COVID-19 |
O. G. Ni, D. V. Troshchansky, D. N. Protsenko, I. N. Tyurin, E. A. Balanyuk |
| 25 |
[GO] |
2021―Jul―03 |
Signs and Symptoms of Central Nervous System Involvement and Their Pathogenesis in COVID-19 According to The Clinical Data (Review) |
N. V. Tsygan, A. P. Trashkov, A. V. Ryabtsev, V. A. Yakovleva, A. L. Konevega, A. G. Vasiliev, et al. (+3) V. N. Tsygan, M. M. Odinak, I. V. Litvinenko |
| 26 |
[GO] |
2021―Jul―03 |
Hemodynamic Parameters After Prone Positioning of COVID-19 Patients |
D. S. Shilin, K. G. Shapovalov |
| 27 |
[GO] |
2021―Jul―03 |
Meglumine Sodium Succinate to Correct COVID-19-Associated Coagulopathy: the Feasibility Study |
I. S. Simutis, G. A. Boyarinov, M. Yu. Yuriev, D. S. Petrovsky, A. L. Kovalenko, K. V. Sapozhnikov |
| 28 |
[GO] |
2021―Jun―10 |
Brain Morphological Changes in COVID-19 |
Anastasia S. Babkina, Arkady M. Golubev, Irina V. Ostrova, Alexei V. Volkov, Artem N. Kuzovlev |
| 29 |
[GO] |
2021―Jun―10 |
Biomarkers of Air-Blood Barrier Damage In COVID-19 |
Maryam B. Khadzhieva, Alesya S. Gracheva, Anton V. Ershov, Yulia V. Chursinova, Vadim A. Stepanov, Lyudmila S. Avdeikina, et al. (+6) Oleg A. Grebenchikov, Anastasia S. Babkina, Aslan K. Shabanov, Alexey V. Tutelyan, Sergey S. Petrikov, Artem N. Kuzovlev |
| 30 |
[GO] |
2021―Apr―29 |
Clinical Phenotypes of Hypoxia in Patients with COVID-19 |
O. V. Voennov, A. V. Turentinov, K. V. Mokrov, P S. Zubееv, S. A. Abramov |
| 31 |
[GO] |
2021―Apr―29 |
Mediastinal Emphysema as a Specific Complication of COVID-19 (Case Report) |
E. P. Pavlikova, M. A. Agapov, P. S. Malakhov, E. A. Galliamov, Yu. S. Esakov, D. R. Markaryan, et al. (+2) V. V. Kakotkin, V. A. Kubyshkin |
| 32 |
[GO] |
2021―Jan―09 |
Hyperbaric Oxygen Therapy in Patients with COVID-19 |
S. S. Petrikov, A. K. Evseev, O. A. Levina, A. K. Shabanov, V. V. Kulabukhov, N. Yu. Kutrovskaya, et al. (+7) N. V. Borovkova, Е. V. Klychnikova, I. V. Goroncharovskaya, E. V. Tazina, K. А. Popugaev, D. A. Kosolapov, D. S. Slobodeniuk |
| 33 |
[GO] |
2020―Jun―23 |
Causal Therapy of COVID-19: Critical Review and Prospects |
N. V. Beloborodova, E. V. Zuev, M. N. Zamyatin, V. G. Gusarov |
| 34 |
[GO] |
2020―May―25 |
Coronavirus SARS-CoV-2: Hypotheses of Impact on the Circulatory System, Prospects for the Use of Perfluorocarbon Emulsion, and Feasibility of Biophysical Research Methods |
Viktor V. Moroz, Alexander M. Chernysh, Elena K. Kozlova |
| 35 |
[GO] |
2020―May―15 |
COVID-19-Related Thromboinflammatory Status: MicroCLOTS and Beyond |
Pasquale Nardelli, Giovanni Landoni |
